Investigator’s Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials

Authors

  • Claudia Zeidler Center for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Von- Esmarch-Str. 58, DE-48149 Münster, Germany
  • Manuel P. Pereira
  • Matthias Augustin
  • Mary Spellman
  • Sonja Ständer

DOI:

https://doi.org/10.2340/00015555-3701

Keywords:

prurigo nodularis, chronic pruritus, itch

Abstract

Chronic prurigo is a pruritic disease characterized by the development of pruriginous lesions due to scratching. The number of lesions is representative of the stage of the disease, while the presence of excoriations reflects the scratching activity. Aim of this study was to validate a new developed tool for the objective assessment of chronic prurigo. Investigator’s Global Assessment scales for stage and activity were completed for 187 patients with chronic prurigo, who also reported patient-reported outcomes for itch intensity and quality of life. To assess the reliability and objectivity of the Investigator’s Global Assessment, 5 independent raters completed the Investigator’s Global Assessment scales for 8 patients twice. The scores increased with increased intensity of pruritus. The Investigator’s Global Assessment stage scales correlated strongly with each other (Kendall’s-tau-b 0.62) and moderately with the Investigator’s Global Assessment activity scale (Kendall’s-tau-b 0.47). Intra-rater test–retest reliability was excellent for all items, while the congruence among raters was very good for Investigator’s Global Assessment – chronic prurigo activity (Kendall’s W 0.84) and good for Investigator’s Global Assessment stage scales (Kendall’s W 0.747). Investigator’s Global Assessment – chronic prurigo stage and activity are thus the best Investigator’s Global Assessment instruments for use in assessing chronic prurigo.

Downloads

Download data is not yet available.

References

Pereira MP, Steinke S, Zeidler C, Forner C, Riepe C, Augustin M, et al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol 2018; 32: 1059-1065.

DOI: https://doi.org/10.1111/jdv.14570

Pereira MP, Hoffmann V, Weisshaar E, Wallengren J, Halvorsen JA, Garcovich S, et al. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. J Eur Acad Dermatol Venereol 2020; 34: 2373-2383.

DOI: https://doi.org/10.1111/jdv.16309

Zeidler C, Stander S. The pathogenesis of prurigo nodularis - 'super-itch' in exploration. Eur J Pain 2016; 20: 37-40.

DOI: https://doi.org/10.1002/ejp.767

Pereira MP, Zeidler C, Nau T, Bobko S, Evers AWM, Garcovich S, et al. Position statement: linear prurigo is a subtype of chronic prurigo. J Eur Acad Dermatol Venereol 2019; 33: 263-266.

DOI: https://doi.org/10.1111/jdv.15275

Schedel F, Schurmann C, Metze D, Stander S. Prurigo. Klinische Definition und Klassifikation. Hautarzt 2014; 65: 684-690.

DOI: https://doi.org/10.1007/s00105-014-2753-z

Bruland P, Hanse W, Schedel F, Stander S, Fritz F. PIACS: A system for the automatic detection, categorization and comparison of scratch-related skin lesions in dermatology. Stud Health Technol Inform 2015; 216: 1042.

Polking J, Zeidler C, Schedel F, Osada N, Augustin M, Metze D, et al. Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo. J Eur Acad Dermatol Venereol 2018; 32: 1754-1760.

DOI: https://doi.org/10.1111/jdv.15040

Siepmann D, Lotts T, Blome C, Braeutigam M, Phan NQ, Butterfass-Bahloul T, et el. Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial. Dermatology 2013; 227: 353-360.

DOI: https://doi.org/10.1159/000355671

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.

DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

Reich A, Chatzigeorkidis E, Zeidler C, Osada N, Furue M, Takamori K, et al. Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol 2017; 97: 759-760.

DOI: https://doi.org/10.2340/00015555-2642

Pereira MP, Mittal A, Ständer S. Current treatment strategies in refractory chronic pruritus. Curr Opin Pharmacol 2018; 46: 1-6.

DOI: https://doi.org/10.1016/j.coph.2018.11.007

Steinke S, Zeidler C, Riepe C, Bruland P, Soto-Rey I, Storck M et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol 2018; 79: 457-463.e5.

DOI: https://doi.org/10.1016/j.jaad.2018.04.044

Schedel F, Schürmann C, Augustin M. Prurigo nodularis: introduction of a re-defined classification and Prurigo Activity Score (PAS). Acta Derm Venereol 2013; 93: 610.

Wong SS, Goh CL. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis. Arch Dermatol 2000; 136: 807-808.

DOI: https://doi.org/10.1001/archderm.136.6.807

Breuer K, Braeutigam M, Kapp A, Werfel T. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Dermatology 2004; 209: 314-320.

DOI: https://doi.org/10.1159/000080855

Simpson E, Bissonnette R, Eichenfield LF. The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis. J Am Acad Dermatol 2020; 83: 839-846.

DOI: https://doi.org/10.1016/j.jaad.2020.04.104

Pereira MP, Steinke S, Bruland P, Ständer HF, Dugas M, Augustin M et al. Management of chronic pruritus: from the dermatological office to the specialized itch center. A review. Itch 2017; 2: e06.

DOI: https://doi.org/10.1097/itx.0000000000000006

Dantas LD, Bakos L, Balbinot G, Drechsler CE, Eidt LM. Prevalence of dermatoses in dermatologic evaluation requests from patients admitted to a tertiary hospital for 10 years. An Bras Dermatol 2015; 90: 762-764.

DOI: https://doi.org/10.1590/abd1806-4841.20153664

Published

2021-02-17

How to Cite

Zeidler, C., Pereira, M. P., Augustin, M., Spellman, M., & Ständer, S. (2021). Investigator’s Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials. Acta Dermato-Venereologica, 101(2), adv00401. https://doi.org/10.2340/00015555-3701